PLAU and pancreatic neoplasm: Lead compounds from these series showed low nM uPA potency, high selectivity for uPA across the serine hydrolase superfamily, no ENaC activity, and in vivo anti-metastatic effects in xenografted mouse models of lung and pancreatic cancer [26,27].